Profiles of the Common GLP-1 Receptor Agonists Note: All may cause significant/severe GI symptoms including nausea, vomiting, retching, gastroparesis, abdominal bloating, and pain
Marso S.P., Daniels G.H., Brown-Frandsen K., et al
Supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892
The Dual Agonist Peptide Advancing Metabolic Research
Custom compounded medications prepared in certified clean rooms backed by adherence to USP guidelines
Because tesamorelin stimulates GH production, patients receiving glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in maintenance or stress doses following initiation of tesamorelin, particularly in patients treated with cortisone acetate and prednisone because conversion of these drugs to their biologically active metabolites is dependent on the activity of 11HSD-1